Sonoma Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Sonoma Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$850K, a 29.6% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$4.28M, a 21.3% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$4.7M, a 2.87% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$4.57M, a 22.4% increase from 2021.
  • Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$5.89M, a 70.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.7M -$131K -2.87% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-17
2022 -$4.57M +$1.32M +22.4% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-17
2021 -$5.89M -$2.44M -70.7% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2020 -$3.45M +$3.94M +53.3% Apr 1, 2020 Mar 31, 2021 10-K 2022-07-13
2019 -$7.39M +$3.87M +34.4% Apr 1, 2019 Mar 31, 2020 10-K 2021-07-14
2018 -$11.3M +$2.93M +20.7% Apr 1, 2018 Mar 31, 2019 10-K 2020-07-10
2017 -$14.2M -$1.22M -9.37% Apr 1, 2017 Mar 31, 2018 10-K 2019-07-01
2016 -$13M +$1.74M +11.8% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-26
2015 -$14.7M -$8.06M -121% Apr 1, 2015 Mar 31, 2016 10-K 2017-06-28
2014 -$6.66M -$608K -10% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-21
2013 -$6.05M -$2.68M -79.3% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-16
2012 -$3.37M +$3.09M +47.8% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 -$6.47M +$1.04M +13.8% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-25
2010 -$7.51M Apr 1, 2010 Mar 31, 2011 10-K 2012-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.